CHAMPION-AF shows Boston Scientific's Watchman FLX as a safe, effective first-line option for stroke risk reduction in ...

The study evaluated the company’s Watchman FLX device, designed to reduce stroke risk in patients with non valvular atrial ...

Boston Scientific Corporation (NYSE:BSX) is one of the 10 Best 52-Week Low NYSE Stocks to Buy Now. On March 29, 2026, Boston ...

In this article, we will look at the 10 Best 52-Week Low NYSE Stocks to Buy Now. Stocks hitting 52-week lows tend to draw ...

Find insight on Novartis, Sanofi and more in the latest Market Talks covering the Health Care sector.

A new Watchman device at McLaren Port Huron offers eligible AFib patients an alternative to long‑term blood thinners to help ...

The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and ...

Boston presented the pair of trial readouts at the 2026 American College of Cardiology (ACC) conference in New Orleans.

NEW ALBANY — Baptist Health Floyd recently completed its 500th Watchman procedure. The Watchman device is an alternative to ...

In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thin | Boston ...

Boston Scientific (BSX) stock tumbled 9% to two-year lows after Watchman trial data revealed stroke concerns and Raymond ...

Boston Scientific Corporation BSX shares are down on Monday as the company faces pressure following a significant clinical ...